Under construction – not a live service
Sign in
Taking people in FranceNo phase

Virtual reality walking practice at home for children with long-term illnesses

Tests home virtual reality walking in children with long-term illnesses.

Key facts

Who runs it
University Hospital, Angers
Where
Angers, FranceSee the site
Trial code
Registry title
EMMVIES : Walking Training at Home in VIrtual Reality for Children With Chronic Illnesses Impacting Physical Health
Status
Recruiting
People taking part
30 people, planned
Started
24 Dec 2025
Expected to end
1 Dec 2027
Type of study
Interventional
Treatments tested
  • EMMVIES program
Record updated
31 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and teenagers aged 6 to 17 with cerebral palsy, a neuromuscular disease, or overweight/obesity, to try a walking program at home with virtual reality.

Age
6 to 17 years
Sex
All sexes can join.
Disease stage
Cerebral palsy with GMFCS level II or III. Neuromuscular disease (spinal muscular atrophy type 3, Duchenne disease, congenital myopathy or Charcot Marie Tooth) with Walton grade 2 to 6 or Vignos grade 3 to 7. Overweight or obesity with BMI above the IOTF-25 percentile.
Earlier treatment
Must have been in a care program for their chronic condition for at least 6 months. Cannot have had surgery, botulinum toxin injections in the legs or intensive therapy in the last 3 months.

Main reasons for not taking part

  • Weight over 100 kg (220 lb)
  • Surgery in the last 3 months
  • Botulinum toxin injections in the legs or intensive therapy in the last 3 months
  • Another non-routine treatment program planned within 5 months
  • Insufficient understanding of French

The registry criteria, word for word

Show all 27 criteriaShow less

Who can take part

  • Patient aged 6 to 17 years at date of inclusion
  • Able to walk for 5 minutes on a treadmill with or without body weight support, with or without technical aids
  • Be able to understand and play virtual reality games (immersive or non-immersive)
  • Be able to answer questionnaires
  • Patient affiliated to or benefiting from a social security scheme
  • Informed consent, dated and signed by parents or guardians (if minors), to participate in the study
  • Included in a care program specific to their chronic condition for at least 6 months
  • Meet the following criteria depending on the group:; PC group:
  • Diagnosis of CP
  • Functional level classified II or III according to the Gross Motor Function Classification System (GMFCS)
  • Rehabilitation goal: improvement of gait and/or gross motor function; OB group:
  • Overweight or obese, defined by a BMI above the IOTF-25 percentile
  • Aim to increase daily physical activity
  • No history of hip pathology; Group NM:
  • Diagnosis of one of the following neuromuscular pathologies: spinal muscular atrophy type 3, Duchenne disease, congenital myopathy or Charcot Marie Tooth
  • Functional level of grade 2 to 6 on the Walton scale, or grade 3 to 7 on the Vignos scale
  • Rehabilitation goal: improvement of walking and/or gross motor skills

Who cannot take part

  • Patients who have undergone surgery in the last 3 months
  • Patients who have received intramuscular botulinum toxin injections in the lower limbs or intensive therapy in the 3 months prior to inclusion
  • Persons under compulsory psychiatric care
  • For children aged 6 to 11: in connection with the immersive virtual reality device: problems with stereoscopic vision (perception of images in 3 dimensions), unstabilized epilepsy, facial trauma < 3 months, hearing or visual impairment, pain, dizziness or nausea caused by using immersive virtual reality
  • Patients weighing over 100 kg (due to the technical constraints of using the AMY mat)
  • Patient with a non-routine therapeutic program planned within 5 months that could lead to confusion with the tested program
  • Patient with insufficient understanding of the French language
  • Patient opposition (child or adolescent)
  • Persons deprived of liberty by judicial or administrative decision
  • Persons under legal protection

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 6 and 17 years old?

Where in France

  • Les CapucinsAngers, FranceContact: Mickaël DINOMAIS, MDTaking people

About the trial

What the trial wants to find out

Over the past 30 years, the prevalence of congenital or acquired chronic diseases in children has risen, affecting between 10 and 30% of them, or at least 100,000 children in France. Pathologies such as cerebral palsy (CP), neuromuscular diseases (NMD), obesity or congenital heart disease impact physical health by causing musculoskeletal, respiratory or cardiovascular deficiencies. These limitations influence their ability to participate in daily activities, affecting their quality of life and that of their families.To minimize these impacts, motor rehabilitation programs focusing on physical activity are proposed, but their effectiveness requires prolonged practice. However, these specific programs, often delivered in remote specialized centers, are difficult to access. Home programs have been developed to overcome these constraints. They enable children, with the support of their parents, to carry out therapeutic activities at home. Although their feasibility has been demonstrated, their effectiveness is relative. A multitude of protocols and tools have been tested, with no harmonization of practices.To support the implementation of home-based programs for children with CP or obesity, virtual reality has already been used, mainly on the basis of commercial solutions. This solution is therefore feasible and has proved relatively effective.With this in mind, and based on the user experience of children, parents and professionals, the investigators have initially co-developed with the French company EzyGain a connected treadmill specifically adapted to pediatric needs and the requirements of home programs. The AMY treadmill is a compact treadmill with on-board sensors and a safety system, communicating with a tablet application and a virtual reality headset.Taking into account the opportunities offered by this new technology, as well as building on the effects and features already known from home programs, the investigators have developed a new modality for home programs focusing on walking for children with CP, MNM and obesity, the EMMVIES program. The crucial step now is to investigate the feasibility, tolerance and clinical effects of this EMMVIES program.

The group in the trial

  • EMMVIES programTreatment being tested

    Evaluate the feasibility of the home training program.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
EMMVIES : Walking Training at Home in VIrtual Reality for Children With Chronic Illnesses Impacting Physical Health
Plain-language title
Virtual reality walking practice at home for children with long-term illnessesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT07021638, who can take part
Record updated
31 December 2025